A retrospective study on aetiology based outcome of infantile spasms

Seizure

Volumn 18, Issue 3, 2009, Pages 197-201

  Karvelas, Georges ^a   Lortie, Anne ^a   Scantlebury, Morris H ^b   Duy, Paul T ^a   Cossette, Patrick ^a,c   Carmant, Lionel ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NOTRE DAME HOSPITAL   (Canada)

Author keywords

Autism; Cognition; Epilepsy; West syndrome

Indexed keywords

CORTICOTROPIN; PREDNISONE; VIGABATRIN;

ARTICLE; BRAIN DAMAGE; CHILD; COGNITION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; EPILEPSY; FEMALE; HUMAN; INFANTILE SPASM; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TUBEROUS SCLEROSIS;

EID: 61349112710     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2008.09.006     Document Type: Article

References (35)

1. Dulac O., Chugani H., and Dalla-Bernardina H. Infantile spasms and West syndrome (1994), Saunders, London
2. Carmant L. Infantile spasms: West syndrome. Arch Neurol 59 (2002) 317-318
3. Lado F.A., and Moshe S.L. Role of subcortical structures in the pathogenesis of infantile spasms: what are possible subcortical mediators?. Int Rev Neurobiol 49 (2002) 115-140
4. Brunson K.L., Avisha-Eliner S., and Baram T.Z. ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 49 (2002) 185-197
5. Brunson K.L., Eghbal-Ahmadi M., and Baram T.Z. How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis. Brain Dev 23 (2001) 533-538
6. Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 23 (2001) 539-541
7. Sidenvall R., and Eeg-Olofsson O. Epidemiology of infantile spasms in Sweden. Epilepsia 36 6 (1995) 572-574
8. Bma P.M., Gordon K.E., Dooley J.M., and Wood E.P. The epidemiology of infantile spasms. Can J Neurol Sci 28 (2001) 309-312
9. Osborne J.P., and Lux A. Towards an international consensus on definitions and standardised outcome measures for therapeutic trials (and epidemiological studies) in West syndrome. Brain Dev 23 (2001) 677-682
10. Mackay M.T., et al. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurology 62 (2004) 1668-1681
11. Engel Jr. J. ILAE classification of epilepsy syndromes. Epilepsy Res 70 Suppl. 1 (2006) S5-S10
12. Nabbout R., Melki I., Gerbaka B., Dulac O., and Akatcherian C. Infantile spasms in Down syndrome: good response to a short course of vigabatrin. Epilepsia 42 (2001) 1580-1583
13. Escofet C., Poo P., Valbuena O., Gassio R., Sanmarti F.X., and Campistol J. Infantile spasms in children with Down's syndrome. Rev Neurol 23 (1995) 315-317
14. Caraballo R., Cersosimo R., Arroyo H., and Fejerman N. Symptomatic West's syndrome: specific etiological link to unexpected response to treatment. Rev Neurol 26 (1998) 372-375
15. Gastaut H., Roger J., Soulayrol R., Saint-Jean M., Tassinari C.A., Regis H., et al. Epileptic encephalopathy of children with diffuse slow spikes and waves (alias "petit mal variant") or Lennox syndrome. Ann Pediatr 13 (1966) 489-499
16. Shields W.D. Diagnosis of infantile spasms, Lennox-Gastaut syndrome, and progressive myoclonic epilepsy. Epilepsia 45 Suppl. 5 (2004) 2-4
17. Cowan L.D., and Hudson L.S. The epidemiology and natural history of infantile spasms. J Child Neurol 6 (1991) 355-364 [Review]
18. Hrachovy R.A., and Frost J.D. Infantile spasms. Pediatr Clin North Am 36 (1989) 311-329
19. Dulac O., Plouin P., and Jambaque I. Predicting favorable outcome in idiopathic West syndrome. Epilepsia 34 (1993) 747-756
20. Miller S.P., Ramaswamy V., Michelson D., Barkovich A.J., Holshouser B., Wycliffe N., et al. Patterns of brain injury in term neonatal encephalopathy. J Pediatr 146 (2005) 453-460
21. Hrachovy R.A. West's syndrome (infantile spasms). Clinical description and diagnosis. Adv Exp Med Biol 497 (2002) 33-50
22. Jambaque I., Chiron C., Dumas C., Mumford J., and Dulac O. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 38 (2000) 151-160
23. Chau V., Karvelas G., and Carmant L. Early treatment of Aicardi syndrome with vigabatrin can improve outcome. Neurology 63 (2004) 1756-1757
24. Kivity S., Lerman P., Ariel R., Danziger Y., Mimouni M., and Shinnar S. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 45 (2004) 255-262
25. Lo Nigro C., Chong S.S., Smith A.C.M., Dobyns W.B., Carrozzo R., and Ledbetter D.H. Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum Mol Genet 6 (1997) 157-164
26. Gleeson J.G., Allen K.M., Fox J.W., Lamperti E.D., Berkovic S., Scheffer I., et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 92 (1998) 63-72
27. Stromme P., Mangelsdorf M.E., Shaw M.A., Lower K.M., Lewis S.M.E., Bruyere H., et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet 30 (2002) 441-445
28. Kitamura K., Yanazawa M., Sugiyama N., Miura H., Iizuka-Kogo A., Kusaka M., et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 32 (2002) 359-369
29. Masruha M.R., Caboclo L.O., Carrete Jr. H., Cendes I.L., Rodrigues M.G., Garzon E., et al. Mutation in filamin A causes periventricular heterotopia, developmental regression, and West syndrome in males. Epilepsia 47 (2006) 211-214
30. Kalscheuer V.M., Tao J., Donnelly A., Hollway G., Schwinger E., Kubart S., et al. Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. Am J Hum Genet 72 (2003) 1401-1411
31. Tao J., Van Esch H., Hagedorn-Greiwe M., Hoffmann K., Moser B., Raynaud M., et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet 75 (2004) 1149-1154
32. Weaving L.S., Christodoulou J., Williamson S.L., Friend K.L., McKenzie O.L.D., Archer H., et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 75 (2004) 1079-1093
33. Yamatogi Y., and Ohtahara S. Multiple independent spike foci and epilepsy, with special reference to a new epileptic syndrome of "severe epilepsy with multiple independent spike foci". Epilepsy Res 70 Suppl. 1 (2006) S96-S104
34. Cossette P., Riviello J.J., and Carmant L. ACTH versus vigabatrin therapy in infantile spasms: a retrospective study. Neurology 52 8 (1999) 1691-1694
35. Lux A.L., Edwards S.W., Hancock E., Johnson A.L., Kennedy C.R., Newton R.W., et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol 4 11 (2005) 712-717